Skip to content

Effect of a Music Therapy Intervention on Mood

Effect of a Music Therapy Intervention on the Mood of the Critical Patient in a Tertiary Hospital.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04127344
Enrollment
164
Registered
2019-10-15
Start date
2019-03-12
Completion date
2020-12-31
Last updated
2020-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically Ill Patient

Brief summary

The hypothesis is that the music therapy intervention has a positive impact on the critical patients' mood as it has a reassuring effect that allows a connection with emotions, helps to communicate and affects the welfare of patients. It also reduces pain and the consumption of painkillers and sedatives, as well as vasoactive drugs in critical patients.

Detailed description

The aim of the study is to assess the effect of a personalised music therapy intervention with standard treatment on critical patients' mood compared to those who just receive the standard treatment. Moreover, the effect of the different interventions on pain and sedative, analgesic and vasoactive drugs will also be assessed. This is a randomized, parallel and open clinical trial that will compare: a) a music therapy intervention combined with the standard care (experimental group), with b) standard care (control group), on critical patients admitted to the General, Cardiac and Coronary Intensive Care Unit of the Santa Creu I Sant Pau Hospital. The expected number of patients expected to be included in this trial is 164. Patients will be included and randomized the day the music therapy intervention is to take place, once a week. Patients' mood will be assessed with a validated questionnaire in Spanish for adults, the POMS (Profile of Mood States) survey that consists of a self-report built on the basis of a multidimensional conception of mood and has a Likert 5-points type format (0 to 4)

Interventions

Patients randomized to a music therapy intervention will receive an individualised music therapy intervention. The sessions will last 10-20 minutes and they will be done by music therapist and musician.

Sponsors

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Randomized clinical trial, parallel and open label.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who are oriented in time, space and person * Glasgow Coma Scale of 15 or 11+intubated * Negative the Confusion Assessment Method for the ICU (CAM-ICU) * Richmond Agitation-Sedation Scale of 0 * Patients who are at least conscious and oriented for 48 hours in the ICU.

Exclusion criteria

* Auditory deficit * Patients that have participated in the study previously

Design outcomes

Primary

MeasureTime frameDescription
Mood state24 hoursThe mood state will be assessed through the Profile of Mood States Scale (POMS) after randomization, within the next 6 to 12 hours, and 24 hours after randomization.

Secondary

MeasureTime frameDescription
Level of pain24 hoursThe level of pain will be assessed through an Analogical Visual Scale after randomization, within the next 6 to 12 hours, and 24 hours after randomization.
Consumption of analgesics and sedatives24 hoursConsumption of analgesics and sedatives will be assessed after randomization, within the next 6 to 12 hours, and 24 hours after randomization.
Consumption of vasoactive drugs24 hoursConsumption of vasoactive drugs will be assessed after randomization, within the next 6 to 12 hours, and 24 hours after randomization.
Physiological variables (blood pressure, heart rate, breathing rate and oxygen saturation)24 hoursThe physiological variables will be assessed after randomization, within the next 6 to 12 hours, and 24 hours after randomization.

Countries

Spain

Contacts

Primary ContactMª del Mar Vega Castosa
MVegaC@santpau.cat+34.649.743.325

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026